1. Home
  2. SKK vs MIRM Comparison

SKK vs MIRM Comparison

Compare SKK & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKK
  • MIRM
  • Stock Information
  • Founded
  • SKK 2013
  • MIRM 2018
  • Country
  • SKK Singapore
  • MIRM United States
  • Employees
  • SKK N/A
  • MIRM N/A
  • Industry
  • SKK
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKK
  • MIRM Health Care
  • Exchange
  • SKK NYSE
  • MIRM Nasdaq
  • Market Cap
  • SKK 11.6M
  • MIRM 2.5B
  • IPO Year
  • SKK 2024
  • MIRM 2019
  • Fundamental
  • Price
  • SKK $0.62
  • MIRM $52.66
  • Analyst Decision
  • SKK
  • MIRM Strong Buy
  • Analyst Count
  • SKK 0
  • MIRM 9
  • Target Price
  • SKK N/A
  • MIRM $66.22
  • AVG Volume (30 Days)
  • SKK 79.0K
  • MIRM 456.2K
  • Earning Date
  • SKK 02-14-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • SKK N/A
  • MIRM N/A
  • EPS Growth
  • SKK 99.13
  • MIRM N/A
  • EPS
  • SKK 0.03
  • MIRM N/A
  • Revenue
  • SKK $11,301,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • SKK N/A
  • MIRM $35.83
  • Revenue Next Year
  • SKK N/A
  • MIRM $16.83
  • P/E Ratio
  • SKK $22.17
  • MIRM N/A
  • Revenue Growth
  • SKK 15.80
  • MIRM 69.31
  • 52 Week Low
  • SKK $0.53
  • MIRM $36.17
  • 52 Week High
  • SKK $11.45
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • SKK N/A
  • MIRM 64.66
  • Support Level
  • SKK N/A
  • MIRM $49.22
  • Resistance Level
  • SKK N/A
  • MIRM $53.86
  • Average True Range (ATR)
  • SKK 0.00
  • MIRM 1.57
  • MACD
  • SKK 0.00
  • MIRM 0.08
  • Stochastic Oscillator
  • SKK 0.00
  • MIRM 79.63

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: